Malignancy risk from genetically modified immune effector cells, p53 immunohistochemistry as a new tool in AML, and phenotypic escape from CD19-directed immunotherapies.
episode
Blood Podcast
not yet transcribed
Transcript
This episode hasn't been transcribed yet
Upvotes decide what gets transcribed next — 0 so far.
Sign in to upvote
Related
recent transcribed audio
Bears are in a race to improve defense as they prepare to face Vikings (Hour 1)
Adam Hoge shares keys to Bears-Vikings matchup (Hour 2)
5 On It & Kevin Fishbain previews Bears-Vikings (Hour 3)
Ben Leber previews Bears-Vikings & we share our predictions (Hour 4)
First Date Follow Up: She Thought He Was a Little Weird on Their First Date… Then She Told Us WHY She Ghosted Him 😂
NPR News: 09-18-2026 3PM EDT